ARCHIVES

Study Suggests Biomarker For Resistance to Tamoxifen

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

More Women Over 50 Report Having Had Mammograms.

July 28, 2000

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997